TY - JOUR
T1 - Curing the brain
T2 - in search for new astrocyte-specific therapies [Incl. Correction]
AU - Verkhratsky, Alexei
AU - Lee, C. Justin
AU - Chun, Heejung
AU - Göritz, Christian
AU - Harkany, Tibor
AU - Lee, Jae Hun
AU - Lee, Sangkyu
AU - Lindskog, Maria
AU - Koh, Wuhyun
AU - Mulder, Jan
AU - Nam, Min Ho
AU - Ottersen, Ole Petter
AU - Pekna, Marcela
AU - Pekny, Milos
AU - Pękowska, Aleksandra
AU - Ryu, Hoon
AU - Sohn, Chang Ho
AU - Tretiakov, Evgenii O.
AU - Untiet, Verena
AU - Viney, Tim J.
AU - Youn, Wongu
AU - Yi, Chenju
AU - Zorec, Robert
AU - Yun, Mijin
AU - Cheong, Eunji
AU - Nordberg, Agneta
N1 - DOI to Correction: 10.1038/s12276-026-01749-5
Link to Correction: https://www.nature.com/articles/s12276-026-01749-5
Publisher Copyright:
© The Author(s) 2026.
PY - 2026
Y1 - 2026
N2 - Astroglia, an extended class of homeostatic and defensive cells of the central nervous system (CNS), contribute to the pathogenesis of all known neurological and neuropsychiatric disorders. The pathophysiology of astrocytes is complex, mutable, disease and disease-stage specific. In neuroinflammatory lesions and in various chronic conditions, astrocytes undergo an evolutionary conserved defensive remodeling known as reactive astrogliosis, which produces highly heterogeneous reactive astrocytic phenotypes. Broadly, reactive astrogliosis can be classified into proliferative anysomorphic barrier-forming astrogliosis characteristic of traumatic CNS lesions and nonproliferative isomorphic gliosis widely manifested in chronic neuropathologies. In addition, in many pathologies, astrocytes undergo atrophy and asthenia with resulting loss of homeostatic support and neuroprotection precipitating neuronal damage. Reactive and atrophic astrocytes may coexist or emerge in sequence in a disease-stage-dependent manner. Several classes of astrocyte-specific molecules and processes implicated in various diseases of the CNS represent therapeutic targets. Astrocyte-specific therapeutic strategies may improve both disease-preventing and disease-modifying therapeutic outcomes.
AB - Astroglia, an extended class of homeostatic and defensive cells of the central nervous system (CNS), contribute to the pathogenesis of all known neurological and neuropsychiatric disorders. The pathophysiology of astrocytes is complex, mutable, disease and disease-stage specific. In neuroinflammatory lesions and in various chronic conditions, astrocytes undergo an evolutionary conserved defensive remodeling known as reactive astrogliosis, which produces highly heterogeneous reactive astrocytic phenotypes. Broadly, reactive astrogliosis can be classified into proliferative anysomorphic barrier-forming astrogliosis characteristic of traumatic CNS lesions and nonproliferative isomorphic gliosis widely manifested in chronic neuropathologies. In addition, in many pathologies, astrocytes undergo atrophy and asthenia with resulting loss of homeostatic support and neuroprotection precipitating neuronal damage. Reactive and atrophic astrocytes may coexist or emerge in sequence in a disease-stage-dependent manner. Several classes of astrocyte-specific molecules and processes implicated in various diseases of the CNS represent therapeutic targets. Astrocyte-specific therapeutic strategies may improve both disease-preventing and disease-modifying therapeutic outcomes.
U2 - 10.1038/s12276-026-01712-4
DO - 10.1038/s12276-026-01712-4
M3 - Review
C2 - 42032208
AN - SCOPUS:105037410555
SN - 1226-3613
VL - 58
SP - 1086
EP - 1127
JO - Experimental and Molecular Medicine
JF - Experimental and Molecular Medicine
IS - 4
ER -